Covered recipient · General Payments record
TREVOR TONKS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Acute Care
General Payments · PY2023–2024
$770.69
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $409.86 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $121.84 | 1 |
| Amgen Inc. | $121.84 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $39.54 | 2 |
| ABBVIE INC. | $39.32 | 2 |
| Celgene Corporation | $30.20 | 1 |
| MIMEDX Group, Inc. | $26.31 | 1 |
| TG THERAPEUTICS, INC. | $17.37 | 1 |
| PFIZER INC. | $13.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.37 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108317579 | CMS |
| ABBVIE INC. | $25.95 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108317581 | CMS |
| Amgen Inc. | $121.84 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117399984 | CMS |
| AstraZeneca Pharmaceuticals LP | $121.84 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104537626 | CMS |
| Celgene Corporation | $30.20 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101144549 | CMS |
| MIMEDX Group, Inc. | $26.31 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140277494 | CMS |
| PFIZER INC. | $13.44 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131171714 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.94 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137834829 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.60 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137834831 | CMS |
| TG Therapeutics, Inc. | $17.37 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136876062 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.